elvn-001
·Code: ELVN-001
elvn-001: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Enliven Therapeutics, Inc. (ELVN) | Phase 1 |
Clinical Trials (1)
A Phase 1 Study of ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants
Frequently asked questions
Who is developing elvn-001?
elvn-001 is being developed by Enliven Therapeutics, Inc..
How many clinical trials involve elvn-001?
BioSniper tracks 1 clinical trial involving elvn-001.
Get deeper analysis on elvn-001
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis